ExecutiveOrdersEO
EO 13937Executive OrderTrump 45 · R

Executive Order 13937

Access to Affordable Life-Saving Medications

This executive order requires Federally Qualified Health Centers (FQHCs) to pass through discounted insulin and epinephrine prices to low-income uninsured or underinsured patients as a condition of receiving future federal grants. The policy aims to make these life-saving medications available at the steep discounts FQHCs already receive through the 340B drug pricing program, plus a minimal administrative fee.

Federal Register Open PDF 85 FR 45755

Impact dates

  1. HHS action to ensure future grants conditioned on FQHC pass-through pricing

Key directives

  • HHS Secretary shall condition future section 330(e) grants on FQHCs establishing practices to make insulin and injectable epinephrine available at 340B discounted prices plus minimal administration fee
  • Eligible individuals: those with low incomes who have high cost sharing, high unmet deductibles, or no health insurance
  • Scope limited to 'future grants' and 'to the extent permitted by law'

Who is ordered

Timeline

Immediate

  • Policy declaration established
  • HHS Secretary directed to take action

Near term (90d)

  • HHS to develop grant conditions for future section 330(e) grants
  • FQHCs to establish pass-through pricing practices

Long term

  • Implementation of grant conditions on future FQHC funding cycles
  • Potential expansion of affordable medication access for eligible low-income patients

Risks & tensions

  • No explicit deadline specified for HHS action—'shall take action' is vague on timing
  • Applies only to 'future grants,' not existing funding, delaying impact
  • Conditioned on 'availability of appropriations' and 'to the extent permitted by law,' creating legal and fiscal escape hatches
  • Definition of 'low incomes' and 'minimal administration fee' left to Secretary's discretion, creating implementation uncertainty
  • Limited to FQHCs that receive 340B discounts; not all uninsured patients live near participating centers
  • EO explicitly disclaims creating enforceable rights, limiting patient recourse
Executive Order 13937: Access to Affordable Life-Saving Medications · Executive Orders